On Invalid Date, Argenx Se (NASDAQ: ARGX) reported Q4 2022 earnings per share (EPS) of N/A, up N/A year over year. Total Argenx Se earnings for the quarter were N/A. In the same quarter last year, Argenx Se's earnings per share (EPS) was N/A.
On Invalid Date, Argenx Se (NASDAQ: ARGX) reported Q4 2022 revenue of N/A up N/A year over year. In the same quarter last year, Argenx Se's revenue was N/A.
What was ARGX's revenue growth in the past year?
As of Q1 2023, Argenx Se's revenue has grown -98.11% year over year. This is 159.67 percentage points lower than the US Biotechnology industry revenue growth rate of 61.56%. Argenx Se's revenue in the past year totalled $10.67 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.